Al entrar a un enlace saldrá de esta página, luego puede regresar manualmente a esta página
Medicamentos
- Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety
- Antiviral Activity of Ivermectin Against SARS-CoV-2: An Old-Fashioned Dog with a New Trick – A Literature Review
- Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment — United States, January–June 2020
- Review of the Emerging Evidence Supporting the Use of Ivermectin in the Prophylaxis and Treatment of COVID-19
- Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic
- Favipiravir: A Potential Antiviral for COVID-19?
- Favipiravir, an antiviral for COVID-19?
- Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit
- ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY – FAVIPIRAVIR
- Compassionate Use of Remdesivir in Covid-19
- Potential Antiviral Drugs Under Evaluation for the Treatment of COVID-19
- Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results
- Preliminary results about dexamethasone use in treating critically ill COVID-19 patients
- Dexametasona en pacientes críticos: resultados en ensayos clínicos. Entre el optimismo y la cautela.
- Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report
- Corticoides para el tratamiento del COVID-19, OMS
- Ibuprofeno y COVID-19
- FDA advierte a empresa que comercializa productos peligrosos de dióxido de cloro que afirman tratar o prevenir el COVID-19
- The SARS-CoV-2 Transcriptional Metabolic Signature in Lung Epithelium
- Novedades Internacionales y Nacionales en Seguridad de Medicamentos
- Cochrane Evidencias tratamiento COVID
- Preliminary results about dexamethasone use in treating critically ill COVID-19 patients
- Ibuprofeno y COVID-19
- Uso de heparina en paciente ambulatorio con COVID-19 no grave.
- Drug treatments for covid-19: living systematic review and network meta-analysis
- Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported
- Uso de heparina en paciente ambulatorio con COVID-19 no grave.
- Treatment of COVID-19 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
- Therapeutic Effects of Ozone Therapy that Justifies Its Use for the Treatment of COVID-19
- COVID-19, SARS CoV-2 Standford guide
- Costa Rica Readies Horse Antibodies for Trials as an Inexpensive COVID-19 Therapy
- El difícil recorrido vital de un medicamento
- Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
- Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline
- COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?
- Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial
- Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome
- Azitromicina y otros macrólidos que se sabe (inglés)
- Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study
- La OMS señala que no existe evidencia actualmente que afirme un agravamiento de la infección por COVID-19 con el ibuprofeno u otros AINEs
- A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
